To round up 2018, we asked our Expert panel to choose their top papers from across the year. Here, you can discover the articles they selected and read about and the reasons why!
Browsing: Disease Area > Bacterial
New research has identified a link between the use of non-steroidal anti-inflammatory drugs – commonly used as pain relief – and more severe C. difficile infections in mouse models.
The International Congress of the European Respiratory Society, 15–19 September, Paris (France), is the largest respiratory medicine meeting in the world. Find out about the latest research on non-tuberculous mycobacteria lung disease (NTM-LD) discussed at the 2018 congress in this report.
Researchers have used genome sequencing to identify the source of the Yemen cholera outbreak, suggesting it is likely to have originated from East Africa.
A bacteriophage, VP882, has been identified to use bacterial quorum-sensing as a method to control the lysis-lysogeny decision. This is the first time a virus has been shown to detect a bacterial molecule.
Want to discover the best research that’s occurred this year? Editor, Martha Powell, highlights the best of 2018’s infectious diseases research in an A–Z.
More focus should be put on determining if pathogens are resistant or resilient to antibiotics, according to a new study. This distinction could allow for improved, personalized treatment and help to preserve current antibiotics.
Scientists exploring the genome of Salmonella enterica Serovar Typhi have unveiled the alarming presence of antimicrobial resistance genes from isolates of the recent outbreak in Bangladesh; new geographical origins and spread of resistance is implicated.
Researchers from the University of Zurich have discovered that thanatin, a compound produced naturally by the spined soldier bug, could target Gram-negative bacteria by preventing formation of the bacteria’s outer membrane – an unprecedented mechanism.